202 related articles for article (PubMed ID: 11060807)
1. Therapeutic potential of anti-inflammatory drugs in focal stroke.
Barone FC; Parsons AA
Expert Opin Investig Drugs; 2000 Oct; 9(10):2281-306. PubMed ID: 11060807
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia.
Barone FC; Irving EA; Ray AM; Lee JC; Kassis S; Kumar S; Badger AM; Legos JJ; Erhardt JA; Ohlstein EH; Hunter AJ; Harrison DC; Philpott K; Smith BR; Adams JL; Parsons AA
Med Res Rev; 2001 Mar; 21(2):129-45. PubMed ID: 11223862
[TBL] [Abstract][Full Text] [Related]
3. SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia.
Barone FC; Irving EA; Ray AM; Lee JC; Kassis S; Kumar S; Badger AM; White RF; McVey MJ; Legos JJ; Erhardt JA; Nelson AH; Ohlstein EH; Hunter AJ; Ward K; Smith BR; Adams JL; Parsons AA
J Pharmacol Exp Ther; 2001 Feb; 296(2):312-21. PubMed ID: 11160612
[TBL] [Abstract][Full Text] [Related]
4. The role of cytokines in the neuropathology of stroke and neurotrauma.
Feuerstein GZ; Wang X; Barone FC
Neuroimmunomodulation; 1998; 5(3-4):143-59. PubMed ID: 9730680
[TBL] [Abstract][Full Text] [Related]
5. Inflammation as a therapeutic target in acute ischemic stroke treatment.
Tuttolomondo A; Di Sciacca R; Di Raimondo D; Renda C; Pinto A; Licata G
Curr Top Med Chem; 2009; 9(14):1240-60. PubMed ID: 19849665
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory mediators and stroke: new opportunities for novel therapeutics.
Barone FC; Feuerstein GZ
J Cereb Blood Flow Metab; 1999 Aug; 19(8):819-34. PubMed ID: 10458589
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets.
Feuerstein GZ; Wang X; Barone FC
Ann N Y Acad Sci; 1997 Oct; 825():179-93. PubMed ID: 9369986
[TBL] [Abstract][Full Text] [Related]
8. Icariin inhibits TNF-α/IFN-γ induced inflammatory response via inhibition of the substance P and p38-MAPK signaling pathway in human keratinocytes.
Kong L; Liu J; Wang J; Luo Q; Zhang H; Liu B; Xu F; Pang Q; Liu Y; Dong J
Int Immunopharmacol; 2015 Dec; 29(2):401-407. PubMed ID: 26507164
[TBL] [Abstract][Full Text] [Related]
9. PR-957 mediates neuroprotection by inhibiting Th17 differentiation and modulating cytokine production in a mouse model of ischaemic stroke.
Guo Y; Chen X; Li D; Liu H; Ding Y; Han R; Shi Y; Ma X
Clin Exp Immunol; 2018 Aug; 193(2):194-206. PubMed ID: 29603201
[TBL] [Abstract][Full Text] [Related]
10. Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor.
Westra J; Doornbos-van der Meer B; de Boer P; van Leeuwen MA; van Rijswijk MH; Limburg PC
Arthritis Res Ther; 2004; 6(4):R384-92. PubMed ID: 15225374
[TBL] [Abstract][Full Text] [Related]
11. MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits.
Kaminska B
Biochim Biophys Acta; 2005 Dec; 1754(1-2):253-62. PubMed ID: 16198162
[TBL] [Abstract][Full Text] [Related]
12. SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia.
Legos JJ; Erhardt JA; White RF; Lenhard SC; Chandra S; Parsons AA; Tuma RF; Barone FC
Brain Res; 2001 Feb; 892(1):70-7. PubMed ID: 11172750
[TBL] [Abstract][Full Text] [Related]
13. p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation.
Gao F; Yue TL; Shi DW; Christopher TA; Lopez BL; Ohlstein EH; Barone FC; Ma XL
Cardiovasc Res; 2002 Feb; 53(2):414-22. PubMed ID: 11827692
[TBL] [Abstract][Full Text] [Related]
14. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target.
Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M
Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344
[TBL] [Abstract][Full Text] [Related]
15. NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats.
Wei HH; Lu XC; Shear DA; Waghray A; Yao C; Tortella FC; Dave JR
J Neuroinflammation; 2009 Aug; 6():19. PubMed ID: 19656406
[TBL] [Abstract][Full Text] [Related]
16. Luteolin Inhibits Fibrillary β-Amyloid
Zhang JX; Xing JG; Wang LL; Jiang HL; Guo SL; Liu R
Molecules; 2017 Feb; 22(3):. PubMed ID: 28245546
[TBL] [Abstract][Full Text] [Related]
17. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
Yego EC; Dillman JF
Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
[TBL] [Abstract][Full Text] [Related]
18. A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.
Munoz L; Ralay Ranaivo H; Roy SM; Hu W; Craft JM; McNamara LK; Chico LW; Van Eldik LJ; Watterson DM
J Neuroinflammation; 2007 Sep; 4():21. PubMed ID: 17784957
[TBL] [Abstract][Full Text] [Related]
19. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
[TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes.
Hedges JC; Singer CA; Gerthoffer WT
Am J Respir Cell Mol Biol; 2000 Jul; 23(1):86-94. PubMed ID: 10873157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
